SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Whittier Trust Co. of Nevada Inc.

Whittier Trust Co. of Nevada Inc. grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 160,402 shares of the exchange traded fund’s stock after purchasing an additional 6,771 shares during the quarter. Whittier Trust Co. of Nevada Inc. owned approximately 0.21% of SPDR S&P Biotech ETF worth $14,445,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after purchasing an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd acquired a new position in SPDR S&P Biotech ETF during the third quarter worth about $141,284,000. Proficio Capital Partners LLC boosted its position in SPDR S&P Biotech ETF by 16,156.1% during the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after acquiring an additional 911,686 shares during the last quarter. Raymond James Financial Inc. acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $55,529,000. Finally, Whittier Trust Co. boosted its position in SPDR S&P Biotech ETF by 3.1% during the fourth quarter. Whittier Trust Co. now owns 320,740 shares of the exchange traded fund’s stock worth $28,885,000 after acquiring an additional 9,713 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 1.0 %

XBI opened at $86.59 on Friday. The firm has a market capitalization of $5.61 billion, a PE ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The firm’s 50-day moving average price is $89.64 and its 200 day moving average price is $94.48.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.